Annual Cash & Cash Equivalents
$81.02 M
+$10.03 M+14.13%
December 31, 2024
Summary
- As of February 22, 2025, SAGE annual cash & cash equivalents is $81.02 million, with the most recent change of +$10.03 million (+14.13%) on December 31, 2024.
- During the last 3 years, SAGE annual cash & cash equivalents has fallen by -$213.21 million (-72.46%).
- SAGE annual cash & cash equivalents is now -95.12% below its all-time high of $1.66 billion, reached on December 31, 2020.
Performance
SAGE Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$81.02 M
-$18.61 M-18.68%
December 31, 2024
Summary
- As of February 22, 2025, SAGE quarterly cash and cash equivalents is $81.02 million, with the most recent change of -$18.61 million (-18.68%) on December 31, 2024.
- Over the past year, SAGE quarterly cash and cash equivalents has dropped by -$18.88 million (-18.90%).
- SAGE quarterly cash and cash equivalents is now -95.12% below its all-time high of $1.66 billion, reached on December 31, 2020.
Performance
SAGE Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SAGE Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +14.1% | -18.9% |
| 3 y3 years | -72.5% | -72.5% |
| 5 y5 years | -36.1% | -36.1% |
SAGE Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -72.5% | +14.1% | -72.5% | +14.1% |
| 5 y | 5-year | -95.1% | +14.1% | -95.1% | +14.1% |
| alltime | all time | -95.1% | +2791.5% | -95.1% | +904.5% |
Sage Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $81.02 M(+14.1%) | $81.02 M(-18.7%) |
| Sep 2024 | - | $99.63 M(-0.3%) |
| Jun 2024 | - | $99.90 M(-42.1%) |
| Mar 2024 | - | $172.65 M(+143.2%) |
| Dec 2023 | $70.99 M(-56.4%) | $70.99 M(-52.3%) |
| Sep 2023 | - | $148.71 M(+22.5%) |
| Jun 2023 | - | $121.42 M(-41.2%) |
| Mar 2023 | - | $206.56 M(+27.0%) |
| Dec 2022 | $162.70 M(-44.7%) | $162.70 M(-18.6%) |
| Sep 2022 | - | $199.83 M(-3.2%) |
| Jun 2022 | - | $206.51 M(+15.6%) |
| Mar 2022 | - | $178.67 M(-39.3%) |
| Dec 2021 | $294.23 M(-82.3%) | $294.23 M(-30.3%) |
| Sep 2021 | - | $422.17 M(-17.9%) |
| Jun 2021 | - | $514.16 M(-42.8%) |
| Mar 2021 | - | $899.25 M(-45.9%) |
| Dec 2020 | $1.66 B(+1211.0%) | $1.66 B(+801.4%) |
| Sep 2020 | - | $184.27 M(-28.6%) |
| Jun 2020 | - | $258.23 M(+29.5%) |
| Mar 2020 | - | $199.44 M(+57.4%) |
| Dec 2019 | $126.70 M | $126.70 M(-51.1%) |
| Sep 2019 | - | $259.18 M(+56.0%) |
| Jun 2019 | - | $166.19 M(-51.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $342.30 M(+79.3%) |
| Dec 2018 | $190.94 M(-37.6%) | $190.94 M(-24.6%) |
| Sep 2018 | - | $253.12 M(-22.3%) |
| Jun 2018 | - | $325.83 M(-41.6%) |
| Mar 2018 | - | $557.55 M(+82.1%) |
| Dec 2017 | $306.24 M(+81.7%) | $306.24 M(+127.0%) |
| Sep 2017 | - | $134.92 M(+1.1%) |
| Jun 2017 | - | $133.45 M(-8.3%) |
| Mar 2017 | - | $145.46 M(-13.7%) |
| Dec 2016 | $168.52 M(-9.8%) | $168.52 M(-47.4%) |
| Sep 2016 | - | $320.08 M(+69.4%) |
| Jun 2016 | - | $189.00 M(-36.9%) |
| Mar 2016 | - | $299.68 M(+60.5%) |
| Dec 2015 | $186.75 M(+46.2%) | $186.75 M(-8.8%) |
| Sep 2015 | - | $204.88 M(-8.6%) |
| Jun 2015 | - | $224.23 M(+98.2%) |
| Mar 2015 | - | $113.16 M(-11.4%) |
| Dec 2014 | $127.77 M(+1484.0%) | $127.77 M(-6.6%) |
| Sep 2014 | - | $136.73 M(+178.3%) |
| Jun 2014 | - | $49.13 M(-11.4%) |
| Mar 2014 | - | $55.42 M(+587.1%) |
| Dec 2013 | $8.07 M(+187.9%) | $8.07 M |
| Dec 2012 | $2.80 M | - |
FAQ
- What is Sage Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Sage Therapeutics?
- What is Sage Therapeutics annual cash & cash equivalents year-on-year change?
- What is Sage Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Sage Therapeutics?
- What is Sage Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Sage Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of SAGE is $81.02 M
What is the all time high annual cash & cash equivalents for Sage Therapeutics?
Sage Therapeutics all-time high annual cash & cash equivalents is $1.66 B
What is Sage Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, SAGE annual cash & cash equivalents has changed by +$10.03 M (+14.13%)
What is Sage Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of SAGE is $81.02 M
What is the all time high quarterly cash and cash equivalents for Sage Therapeutics?
Sage Therapeutics all-time high quarterly cash and cash equivalents is $1.66 B
What is Sage Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, SAGE quarterly cash and cash equivalents has changed by -$18.88 M (-18.90%)